Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

69th Pharmacy Practice Seminar • PPS 2021 CORE


 
PPS-CORE is an on-demand CPE activity that features key practice highlights presented during the live Annual Pharmacy Practice Seminar (PPS).  This condensed self-study version offers 15.75 hours of CPE credits that meet current Texas State Board of Pharmacy CPE requirements and include such topics as Texas Pharmacy Law, mental health, immunization updates, practical clinical updates, COVID-19 treatment updates, and much more.  The Pharmacy Practice Seminar has traditionally been offered live in-person by The University of Texas at Austin College of Pharmacy, dating back to 1952.  Now pharmacists and technicians who missed the annual live event can still access key practice updates from the event by taking the on-demand CORE version!   PPS-CORE is intended for pharmacists and pharmacy technicians who practice in community and independent pharmacy settings.
 
 
 
 
How it Works • Super Easy
  • Register:  Register below using the green button then bookmark this page for easier access when logging back in.
  • View Presentation Video: Once you are registered and logged in, just click on the title of the session you wish to view/complete (sessions listed below), and follow the instructions for that session.
  • Assessments:  After you have viewed the entire video, click on "take the test" button to complete the brief post-test with a score > 70% within 5 attempts.
  • Evaluations: Once you pass the post-test, the evaluation button will appear.   Submit the evaluation, then CPE credit will automatically submit to CPE Monitor using your NABP e-ID that you entered when registering for this activity (click "my profile" at the top right of the screen and ensure you have entered the correct NABP number and date of birth).  Allow up to 4 business days for the credits to appear in CPE Monitor.
 
 
 
 
Already Registered / Logging Back In 
If you previously registered for this on-demand course, just follow the instructions below to continue completing sessions:
  • On the PPS-CORE website, click Pending/Private Programs in the gray menu bar at the top of the page.
  • Enter your email/password at the prompt.
  • Under the Online CE Tab, select the activity title (PPS-CORE).
  • Continue completing the sessions listed below by clicking a session title and following the instructions for that session.

 
 
2022 Pharmacy Practice Seminar
Join us LIVE next Fall in Austin, Texas for the Annual Pharmacy Practice Seminar (PPS)  - Keep your schedule open for September 2022 (exact date coming soon!).   The live Pharmacy Practice Seminar (PPS) offers 20+ hours of timely and relevant CPE programming to allow participants to pick and choose topics that are most relevant to their own practice needs.  Interested in attending the next LIVE PPS?  Visit the official PPS website for more information.
 

 
Questions?
Email the UT Austin College of Pharmacy CPE staff at UTpharmacyCE@austin.utexas.edu.  Please note:  while CE staff continues working remotely, the fastest way to reach one of us is via email.  Calling the office and leaving a message may result in a delayed response. We apologize for any inconvenience.
 

 

Fee

$360.00

CE Hours

15.75

CE Units

1.575

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Requirements for CE Credit

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This knowledge-based activity is approved for a maximum of 15.75 CPE hours (home study).  In order to receive 15.75 CPE hours of credit, the participant must view each video activity, pass each learning assessment (> 70%, within 5 attempts) then complete an online evaluation for each accredited session.  After each online evaluation is submitted, CPE credit for that session is transmitted directly to CPE Monitor within one week. 

 

 

 

   

 
2021 Immunization Update - 2 CE hours
on-demand home study session
 

About the Faculty

Sharon Rush, RPh
Clinical Associate Professor
The University of Texas College of Pharmacy


Presentations: 2021 Immunization Updates 

Bio:  Sharon Rush received her Bachelor of Science in Pharmacy degree in 1986. She practiced as a staff pharmacist, pharmacy manager, Central Texas Immunization Coordinator, and PGY-1 residency preceptor during her 23 years with a large community pharmacy chain. She joined the faculty of the Division of Pharmacy Practice at The University of Texas at Austin College of Pharmacy in July 2010. She is the Community Introductory Pharmacy Practice Experience Coordinator for the college and the Austin/Temple/Waco Community Advanced Pharmacy Practice Experience Coordinator for the fourth year professional students.
 
Professor Rush has been involved with direct patient care programs for many years, such as pharmacy-based immunizations, health screenings, Medication Therapy Management, and Disease State Management. She is a certified instructor for the APhA Pharmacy-Based Immunization Delivery certificate program for both pharmacists and pharmacy technicians, the APhA Medication Therapy Management certificate program, and the NACDS Point of Care certificate program. All PharmD students at UT earn their immunization and medication therapy management certificates under her instruction.
 
She provides the annual 3-hour continuing education Immunization Update for the Texas Pharmacy Association and The University of Texas College of Pharmacy Pharmacy Practice Seminar. She is a member of several national, state and local professional organizations and serves on the Texas Pharmacy Association’s Public Policy Council and Association Affairs Council. She recently was selected to serve on APhA-APPM’s Immunizing Pharmacists SIG Communications committee and the American Academy of Colleges of Pharmacy Council of Faculties Professional Identity Formation task force.

Disclosure:  Sharon Rush does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

Objectives

  • Identify changes or updates to the January 2021 Immunization Schedules for persons aged 0 through 18 years and adults.
  • Evaluate the most current Advisory Committee on Immunization Practices (ACIP) recommendations and CDC best practice guidelines.
  • Discuss vaccines under investigation or in the pipeline.

Activity Number

0067-0000-21-138-H06-P/T

Release Date: Sep 10, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

2.00
   

   

 
Immunizations and COVID-19:  Where Are We Now?
on-demand home study session
 

About the Faculty

Sharon Rush, RPh
Clinical Associate Professor
The University of Texas College of Pharmacy


Presentations: Immunizations and COVID-19 - Where Are We Now and Where Are We Headed? 

Bio:  Sharon Rush received her Bachelor of Science in Pharmacy degree in 1986.  Sharon Rush practiced as a staff pharmacist, pharmacy manager, Central Texas Immunization Coordinator and PGY1 residency preceptor during her 23 years with a large community pharmacy chain.  She has been involved with different patient care programs such as pharmacy-based immunizations, health screenings, Medication Therapy Management and Disease State Management. is a certified instructor for the APhA “Pharmacy-Based Immunization Delivery” certficate program, the APhA “Delivering Medication Therapy Management Services in the Community” certificate program and is an American Heart Association Basic Life Support instructor.  She was honored with the “Friend of UT-APhA-ASP” award in 2010 and 2011 for her involvement with their health screening events.
Disclosure:  Sharon Rush does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Objectives

  • Discuss the status of COVID-19 with regards to immunizations and variants in U.S.
  • Examine the impact of COVID-19 pandemic on the status of non-covid vaccinations/preventable diseases.
  • Discuss vaccine hesitancy and special populations who may not wish to receive the COVID-19 vaccine and the impact/forecast on reaching herd immunity in the U.S.

Activity Number

0067-0000-21-147-H06-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

1.25
   

   

 
The Impact of COVID-19 on Mental Health in Older Adults
on-demand home study session
 
This module may be counted as one hour of CE related to Mental Health Awareness, as outlined by TSBP rule 295.8(d)(1)(D).
 

About the Faculty
 
Cherie Simpson, PhD, APRN-CNS
Senior Adults Specialty Healthcare

Presentation:  The Impact of COVID-19 on Mental Health in Older Adults

Bio: Cherie Simpson, PhD, APRN-CNS is currently a Clinical Nurse Specialist with Senior Adult Specialty Healthcare, where she provides medical management to geriatric psychiatric patients, predominantly with a diagnosis of dementia.  Cherie earned her MBA from St. Edward's University and continued on to earn a masters in Adult Health Nursing and her Doctorate in nursing at The University of Texas at Austin School of Nursing.  Cherie has years of experience conducting and disseminating scholarly research, while completing her graduate studies at The University of Texas School of Nursing and throughout her practice career. Cherie's extensive research experience in the field of psychiatry is demonstrated by her countless publications and presentations at a local, regional and national level.  Cherie has also received multiple honors and awards over the years for her studies, research and publications in psychiatric practice and continues to actively serve on a wide variety of professional service organizations.


Disclosure: Cherie Simpson does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
 

 

Objectives

  • Explain how the COVID-19 pandemic has affected the mental health of older adults.
  • Describe strategies (healthy and unhealthy) that many seniors have employed to cope during the pandemic.
  • Identify how healthcare providers can support seniors during the pandemic.

Activity Number

0067-0000-21-148-H01-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

1.00
   

   

mRNA vs. DNA Therapies - Current and Future Applications
on-demand home study session
 

Zhengrong Cui, Ph.D. Professor of Molecular Pharmaceutics and Drug Delivery Alfred and Dorothy Mannino Fellow in Pharmacy

 
Presentation:  mRNA and DNA Therapies - Current and Future Applications
Bio: Zhengrong Cui is a Professor at The University of Texas at Austin (UT Austin), College of Pharmacy, Division of Molecular Pharmaceutics and Drug Delivery. His research interests lie in pharmaceutical drug and vaccine delivery. He also has extensive experience in freeze drying of biologics and their needle-free delivery. Dr. Cui published extensively in the fields of pharmaceutics, vaccinology, and nanotechnology, including numerous peer-reviewed research papers, review papers, and book chapters. He is a co-inventor on many patents and patent applications. He serves as an editor to International Journal of Pharmaceutics, and as a reviewer for numerous scientific journals as well as national and international funding agencies. Dr. Cui teaches Biopharmaceutics to professional Doctor of Pharmacy students and Advanced Biopharmaceutics to graduate students and is a UT Austin Provost’s Teaching Fellow. Dr. Cui holds a Ph.D. degree in Pharmaceutical Sciences from the University of Kentucky, College of Pharmacy and completed his postdoctoral training at the University of Pittsburgh, School of Pharmacy. He is a Fellow of the American Association for Pharmaceutical Scientists.
Disclosure: Zhengrong Cui does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

Objectives

  • Describe the mechanism of action of mRNA therapies and how they differ from DNA therapies.
  • Examine the current and future applications of these therapies in healthcare.
  • Discuss potential ethical considerations with mRNA or DNA therapies.

Activity Number

0067-0000-21-150-H01-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

1.00
   

   

 
Texas Pharmacy Law Update
on-demand home study session
 

About the Faculty

Allison Vordenbaumen Benz, RPh, MS Former Executive Director / Secretary Texas State Board of Pharmacy


Presentation:  Texas Pharmacy Law Update
Bio: Allison Vordenbaumen Benz graduated from the University of Texas, College of Pharmacy in August 1988 and completed a Master’s of Science degree in Pharmacy Administration through the Option II program at the University of Texas at Austin in December 1994. Following graduation, she worked as a community pharmacist in California and Texas. Allison has been an employee of the Texas State Board of Pharmacy since August 1994 and has served for 6-years as Senior Enforcement Officer, 3-years as Assistant Director of Enforcement, and 14-years as Director of Professional Services before being appointed to her present position on December 1, 2017. In her position as Executive Director, Allison serves as the chief executive officer of the agency and an ex-officio member and secretary of the Board. Allison is a member of the Capital Area Pharmacy Association; the National Association of State Controlled Substances Authorities; the National Alliance for Model State Drug Laws, Prescription Monitoring Program Resource Group; and the National Charity League, Inc., Capital of Texas Chapter. Her awards include the Texas Pharmacy Association, “Forty Under 40” Award in July 2006.
Disclosure: Allison Benz does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

Objectives

  • Cite recent changes in pharmacy laws and rules and their impact on daily practice.
  • Discuss applicability of Texas Pharmacy Laws to preceptor development.
  • Discuss specific practice scenarios/questions regarding Texas pharmacy laws and rules.

Activity Number

0067-0000-21-143-H03-P/T

Release Date: Sep 11, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

1.25
   

   

2021 New Drug Update
on-demand home study session
 
About the Faculty:
 
Laurajo Ryan, PharmD, MSc, BCPS, CDE
Clinical Associate Professor
University of Texas College of Pharmacy
UT Health Science Center San Antonio

Laurajo Ryan, PharmD, MSc, BCPS, CDE is a Clinical Associate Professor in the Pharmacotherapy Division at the University of Texas College of Pharmacy and at the UT Health Science Center San Antonio in the Department of Medicine and the Pharmacotherapy Education Research Center. She teaches extensively in the College of Pharmacy as well as the School of Medicine. She also serves as a scientific reviewer for an investigational review board (IRB).  She received her Doctor of Pharmacy degree from the University of Texas and completed a 2-year specialty residency at the University of Maryland. She received her Master’s degree in Clinical Investigation from the UT Health Science Center in San Antonio.  Her primary clinical practice is on the inpatient medicine service at University Hospital where she supervises Pharm.D. interns and residents on acute care medicine. She also sees patients in the South Texas VA therapeutic drug management clinic. Her academic responsibilities include didactic teaching of Pharm.D. students, Master’s students, PhD students and residents.

Disclosure: Dr Ryan does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).


Justin Pedigo, Pharm.D., BCPS
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy

Justin Pedigo is a clinical assistant professor and Regional Internship Program Director for the San Antonio region at the University of Texas at Austin College of Pharmacy, and he completed his Doctor of Pharmacy training at Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy in Abilene, Texas. Dr. Pedigo completed a two-year Pharmacotherapy Residency in Lubbock, Texas with TTUHSC, and afterwards he served as a drug information clinical practice specialist with the University of Texas Medical Branch Correctional Managed Care in Huntsville, Texas. Dr. Pedigo provides drug information consultant services to the Texas Department of Health and Human Services Vendor Drug Program and University Health Systems. As a drug information pharmacist, Dr. Pedigo has provided evidence-based population health services to the state offender population including writing evidence-based treatment guidelines and algorithms, and he has provided education to a wide array of healthcare professionals.


Disclosure: Dr Pedigo does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).


 

Objectives

  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses and dosing of selected prescription drugs recently marketed.
  • Examine the role of currently marketed and emerging therapeutics in the prevention/management of COVID-19.

Speaker(s)/Author(s)

Justin Pedigo picture

Justin Pedigo, PharmD, BCPP
Clinical Assistant Professor, The University of Texas College of Pharmacy

Laurajo Ryan, PharmD, MSc, BCPS, CDE picture

Laurajo Ryan, PharmD, MSc, BCPS, CDE, Pharm.D., MSc, BCPS, CDE
Clinical Associate Professor, UT Austin College of Pharmacy / UTHSCSA

Activity Number

0067-0000-21-114-H01-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

1.25
   

   

 
Heart Failure and High Cholesterol:  Implications of Treatment Guidelines
on-demand home study session
 

About the Faculty
 
James Karboski, PharmD

James A. Karboski, PharmD
Clinical Professor of Pharmacy Practice Neill B. Walsdorf Fellow in Pharmacy
The University of Texas at Austin College of Pharmacy

 
Presentation:  Heart Failure and High Cholesterol:  Practical Implications of Treatment Guidelines
Bio: Dr. Karboski earned a Bachelor of Pharmacy degree from Washington State University in 1985. Subsequently, Dr. Karboski earned his Doctor of Pharmacy degree from the University of Texas at Austin and the University of Texas Health Sciences Center at San Antonio in 1987. He continued his training in Texas where he completed a Clinical Sciences Fellowship in Pharmacokinetics at the University of Texas at Austin. Later, while a faculty member at the University of Iowa, Dr. Karboski was a Geriatrics Fellow of the Iowa Geriatrics Education Center. Dr. Karboski directed the Adult Internal Medicine Residency program in collaboration with Brackenridge Hospital for 15 years, supervised 14 residents and created a program that is nationally recognized as a superior training program for future academicians. Dr. Karboski has authored numerous scientific and professional articles in the areas of clinical therapeutics and pharmacokinetics. He has presented over 200 times before various professional, scientific and student groups. Dr. Karboski is recognized for his contributions to teaching excellence and the use of technology in teaching. Dr. Karboski teaches extensively in the undergraduate, Pharm.D., and graduate programs at the University of Texas. He has been nominated for the prestigious Texas Exes Teaching Award for seven of the last eight years and won the award in 2000. He has been nominated for the Regents’ Outstanding Teaching Award for the past two cycles and has been cited by the P4 class as a faculty member who had the highest impact on their professional development for each of the past six years. He has served as the Section Editor – Cardiovascular Diseases for the APhA Drug Treatment Protocols, Section Editor – Cardiovascular Diseases for ASHP’s PharmPrep 3rd Edition, Chair of the Biomedical Research Group Investigational Review Board and item writer and board member for the NABP Foreign Pharmacy Equivalency Exam.
Disclosure: James A. Karboski does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

Objectives

  • Discuss Opening Remarks PPS 2021 - Jennifer Bosworth, PharmD, Assistant Director, UT CPE
  • Discuss the impact of guidelines / evidence-based data on the treatment of heart failure.
  • Discuss the impact of guidelines / evidence-based data on the treatment of high cholesterol.
  • Identify treatment options for heart failure and/or high cholesterol based on patient-specific information and treatment guidelines.

Activity Number

0067-0000-21-139-H01-P/T

Release Date: Sep 11, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

1.25
   

   

 
What Every Pharmacist Needs to Know About Buprenorphine for OUD
on-demand home study session
 
NOTE:  This module may be counted as one hour of CE related to Prescribing and Monitoring Controlled Substances as outlined by TSBP rule 295.8(d)(1)(C)
 

About the Faculty
 
Lucas G. Hill, PharmD
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
 
Bio: Lucas G. Hill graduated from the UMKC School of Pharmacy and completed a combined residency/fellowship in the UPMC Department of Family Medicine. He is now a clinical assistant professor of pharmacy practice at The University of Texas at Austin College of Pharmacy. Dr. Hill is Director and Principal Investigator of Operation Naloxone, an interprofessional opioid overdose prevention program funded through the Texas Targeted Opioid Response. His research is focused on clinician-community collaborations to address substance use disorders through evidence-based treatment and harm reduction strategies. Dr. Hill coordinates the first year of the UT Foundations for Interprofessional Collaborative Practice curriculum and leads the embedded addiction module. He provides an additional 16 hours of addiction-related instruction in the required pharmacy curriculum and precepts both the overdose prevention service IPPE and addiction medicine elective APPE. He also serves as faculty advisor for the UT Student Pharmacist Recovery Network. In 2018, Dr. Hill was awarded the GenerationRx Champion Award for excellence in addiction-related education by the Texas Pharmacy Association and Cardinal Health.
 
Disclosure: Lucas Hill receives financial support from the Substance Abuse and Mental Health Services Administration and the Texas Health and Human Services


 
 

Lindsey J. Loera, Pharm.D.
PhARM Fellow
The University of Texas at Austin College of Pharmacy
Clinical Pharmacist, CARMAhealth Management, Inc

Bio: Dr. Loera graduated from The University of Texas at Austin College of Pharmacy in May 2020 and is currently completing a two-year fellowship with the Pharmacy Addictions Research & Medicine (PhARM) Program. In this role, she is developing an innovative clinical pharmacy practice at an outpatient medical home for substance use disorders and conducts statewide research exploring the pharmacist’s role in addiction treatment. She previously served as President of the Student Pharmacist Recovery Network and co-founded the Addiction Medicine Advanced Pharmacy Practice Experience.
 
Disclosure: Lindsey J. Loera does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

 

Objectives

  • Recall mechanism, formulations, dosing, and regulations related to buprenorphine.
  • Describe evidence supporting safety and efficacy of buprenorphine.
  • Discuss current ethical and legal controversies related to buprenorphine

Activity Number

0067-0000-21-142-H05-P/T

Release Date: Sep 11, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

1.25
   

   

This project is funded by Texas Health & Human Services Texas Targeted Opioid Response
 
Management of Acute Pain in Patients with Opioid Use Disorder
on-demand home study session
NOTE:  This module may be counted as one hour of CE related to Pain Management, as outlined by TSBP rule 295.8(d)(1)(B).
 
About the Faculty 
Dr. Kirsten Mason is a graduate of the University of Tennessee Health Science Center College of Pharmacy. She completed her PGY1 Pharmacy Residency at Memphis Veterans Affairs Medical Center and her PGY2 Internal Medicine Residency at University Medical Center Brackenridge in Austin, TX. Immediately after residency training, Dr. Mason accepted a clinical pharmacy specialist position in cardiology at Northwestern Memorial Hospital in Chicago. In 2016, she had an opportunity to relocate back to Austin and she joined Dell Seton Medical Center at University of Texas as an Internal Medicine Clinical Pharmacy Specialist. In this role, she assisted in the development of an inpatient opioid use disorder treatment service. In November of 2018, Dr. Mason transitioned roles within Ascension Texas to a Regional Clinical Pharmacy Manager with an emphasis on project management and pain management. She also serves as a preceptor for University of Texas College of Pharmacy and Texas A&M College of Pharmacy. Dr. Mason continues to advocate for treatment of opioid use disorder across the continuum of care and educate healthcare providers about medications for opioid use disorder. More recently, Dr. Mason is serving as Interim Director of Pharmacy at Ascension Seton Northwest.

Disclosure: Dr. Mason has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

  • Consultant: Macromoltek Grant Consultant

Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content, and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.


This module may be counted as one hour of CE related to Pain Management, as outlined by TSBP rule 295.8(d)(1)(B)

 

Speaker(s)/Author(s)

Kirsten Mason, PharmD, BCPS, PharmD, PCPS
Clinical Pharmacy Manager, Seton Healthcare Family

Activity Number

0067-0000-21-108-H08-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

1.00
   

   

 
Shining a Light on Migraines:  A Closer Look at Treatment and Prevention
on-demand home study session
 

About the Faculty

Kristin M. Janzen, PharmD, BCPS
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy


Presentation: Shining a Light on Migraines: A Closer Look at Treatment and Prevention
Bio: Kristin Janzen is a Clinical Assistant Professor at the University of Texas at Austin College of Pharmacy. After graduating from UT College of Pharmacy, she completed a combined PGY1 & 2 Pharmacotherapy residency at Butler University and Indiana UniversityHealth in Indianapolis, IN, where she stayed on faculty for a year prior to returning home to UT. She currently practices at Dell Seton Medical Center at the University of Texas in Internal Medicine, where she precepts APPE students and residents on academic internal medicine rotations. Her research and teaching interests focus on core medicine disease states, such as pulmonology, cardiology, diabetes, and interprofessional education.
Disclosure: Kristin Janzen has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.

 

Objectives

  • Differentiate symptoms of headache, migraines and potentially life-threatening conditions for the purpose of referring patients to appropriate treatment or medical attention.
  • Describe new and existing prescription medications used for the prevention of migraine headaches.
  • Describe new and existing prescription medications used for the treatment of migraine headaches.
  • Examine the impact and treatment of migraines in children/adolescents.

Activity Number

0067-0000-21-146-H01-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

1.25
   

   

Pancreatic Cancer Update
on-demand home study session
 

Scott Soefje, PharmD, MBA, BCOP, FCCP 

Director, Pharmacy Cancer Care
Mayo Clinic Assistant Professor of Pharmacy
Mayo Clinic College of Medicine and Science

 
Presentation:  Pancreatic Cancer Update
Bio: Scott earned his BS Pharmacy from UT Austin and then after five years of hospital practice, he returned to earn a PharmD from UT Austin. He completed a Specialty Residency in Oncology Pharmacy at the San Antonio VA and a Clinical Pharmacology Fellowship at the M.D. Anderson Cancer Center. He obtained an MBA from George Washington University. He has been Board Certified in Oncology Pharmacy since 2000.
Disclosure: Scott Soefje has disclosed the following relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence):  Note:  UT CPE mitigated the following financial relationships by having Dr. Soefje's content peer-reviewed prior to the activity by a knowledgeable practitioner who has no relevant financial relationships.  The review ensured the content is valid and free from commercial influence. Pfizer - Speaker's Bureau Merck - Consulting Beigene - Consulting

 

Objectives

  • Examine briefly treatment approaches for pancreatic cancer.
  • Discuss challenges to treating this cancer.
  • Discuss opportunities for pharmacists to support patients with pancreatic cancer.

Speaker(s)/Author(s)

Scott Soefje, Pharm.D., MBA, BCOP, FCCP picture

Scott Soefje, Pharm.D., MBA, BCOP, FCCP
Director of Pharmacy, University Medical Center Brackenridge

Activity Number

0067-0000-21-149-H01-P/T

Release Date: Sep 12, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

1.00
   

   

Pharmacist Analysis of Drug Diversion
on-demand home study session
 
Diane Ginsburg does not have any relevant financial relationships to disclose.

Objectives

  • Describe drugs involved in diversion and the impact on the opioid crisis
  • Discuss how to identify potential prescribing and diversion red flags and action steps regarding suspicious activities

Speaker(s)/Author(s)

Diane B. Ginsburg, Ph.D., M.S., R.Ph., FASHP  picture

Diane B. Ginsburg, Ph.D., M.S., R.Ph., FASHP
Associate Dean for Healthcare Partnerships / Chair and Clinical Professor of Pharmacy Practice, University of Texas at Austin College of Pharmacy

Activity Number

0067-0000-21-152-H03-P/T

Release Date: Sep 10, 2021
Credit Expiration Date: Sep 12, 2023

CE Hours

1.00
   

   

503B Outsourcing Facilities:  What is the Impact on Pharmacy Practice
on-demand home study session
 

About the Faculty
 

Greg Rockers, R.Ph.
Managing Director
The Williamson Rockers Group,LLC

Bio: Greg is Managing Director for The Williamson Rockers Group (WRG). WRG is a consulting firm that helps peers and colleagues in the sterile compounding industry achieve and maintain regulatory compliance. WRG brings an owner's mentality to its consulting engagements. WRG “thinks like owners,” because its consultants have walked in your shoes. Greg has over 27 years of experience in pharmacy management, 17 years of experience in 503A/503B sterile compounding and 18 years of experience in pharmaceutical research. He has operated two 503B Outsourcing Facilities, has assisted organizations in navigating multiple FDA inspections and now conducts audits for 503A and 503B facilities. Greg has real-world, hands-on experience in all facets of running an FDA compliant compounding facility including aseptic processing, formulation development, cGMP gap analysis and remediating 483 observations. Additional areas of emphasis include helping clients buy, sell and raise capital as well as insurance policy exposure audits.
 
Disclosure: Greg Rockers is Managing Director of The Williamson Rockers Group, a consulting firm that helps peers and colleagues navigate the sterile compounding industry.  This financial relationship was mitigated with a peer-review of content prior to the activity by a knowledgeable practitioner who has no relevant financial relationships. The review ensured the content is valid and free from commercial influence.


 

Brian Williamson, PharmD
Managing Director
The Williamson Rockers Group, LLC

Bio: Brian is Managing Director for The Williamson Rockers Group (WRG). WRG is a consulting firm that helps peers and colleagues in the sterile compounding industry achieve and maintain regulatory compliance. WRG brings an owner's mentality to its consulting engagements. WRG “thinks like owners,” because its consultants have walked in your shoes.  Brian uses his expertise in the sterile pharmaceutical compounding industry to help business owners and senior leaders maximize the value in their businesses. As a former founder, owner and operator of a nationally recognized sterile compounding pharmacy and FDA-registered 503B Human Drug Outsourcing Facility, Williamson gained the real-world, hands-on experience that is vitally important to assist other firms in executing financial and quality strategies for success. Brian successfully sold his sterile pharmaceutical compounding firm, JCB Laboratories, in 2014. One of the biggest mistakes he admits he made was not retaining the help of professional investment bankers to help with the process. He now advises business owners that using “do-it-yourself” financial and regulatory readiness is often the best way to leave significant money on the table when closing day comes.
 
Disclosure: Brian Williamson is Managing Director of The Williamson Rockers Group, a consulting firm that helps peers and colleagues navigate the sterile compounding industry.  The financial relationship was mitigated with a peer-review of content prior to the activity by a knowledgeable practitioner who has no relevant financial relationships. The review ensured the content is valid and free from commercial influence.

 

Activity Number

0067-0000-21-140-H04-P/T

Release Date: Sep 11, 2021
Credit Expiration Date: Sep 11, 2023

CE Hours

1.25